| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |